Copyright
©The Author(s) 2021.
World J Gastroenterol. Jun 14, 2021; 27(22): 3130-3137
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.3130
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.3130
Figure 1 Fecal calprotectin content detected in stool with or without severe acute respiratory syndrome coronavirus 2 virus.
SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.
Figure 2 Comparison of patients with and without fecal severe acute respiratory syndrome coronavirus 2 shedding.
SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.
- Citation: Zerbato V, Di Bella S, Giuffrè M, Jaracz AW, Gobbo Y, Luppino D, Macor P, Segat L, Koncan R, D'Agaro P, Valentini M, Crocé LS, Ruscio M, Luzzati R. High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study. World J Gastroenterol 2021; 27(22): 3130-3137
- URL: https://www.wjgnet.com/1007-9327/full/v27/i22/3130.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i22.3130